Elite Pharmaceuticals, Inc. Payments of Loan Costs
Elite Pharmaceuticals, Inc. (ELTP) reported Payments of Loan Costs of $22.56 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfLoanCosts · last filed 2026-08-13
- Elite Pharmaceuticals, Inc. payments of loan costs for the quarter ending 2026-06-30 was $22.56K, a 41.41% decline year-over-year.
- Elite Pharmaceuticals, Inc. payments of loan costs for the quarter ending 2026-03-31 was $22.88K, a 65.50% decline year-over-year.
- Elite Pharmaceuticals, Inc. payments of loan costs for the quarter ending 2025-12-31 was $27.25K, a 74.08% decline year-over-year.
- Elite Pharmaceuticals, Inc. payments of loan costs for the quarter ending 2025-09-30 was $32.11K, a 69.08% decline year-over-year.
- Elite Pharmaceuticals, Inc. payments of loan costs for fiscal 2026 was $120.74K, a 68.13% decline from fiscal 2025.
- Elite Pharmaceuticals, Inc. payments of loan costs for fiscal 2025 was $378.86K, a 104.07% increase from fiscal 2024.
- Elite Pharmaceuticals, Inc. payments of loan costs for fiscal 2024 was $185.65K, a 51.36% decline from fiscal 2023.
- Elite Pharmaceuticals, Inc. payments of loan costs for fiscal 2023 was $381.68K.
| Period end | Payments of Loan Costs 3 month | Payments of Loan Costs 6 month | Payments of Loan Costs 9 month | Payments of Loan Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $22.56K 10-Q · filed 2026-08-13 | $45.44K derived: sum of 2 quarters · filed 2026-08-13 | $72.69K derived: sum of 3 quarters · filed 2026-08-13 | $104.80K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $22.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $50.13K derived: sum of 2 quarters · filed 2026-06-29 | $82.24K derived: sum of 3 quarters · filed 2026-06-29 | $120.74K 10-K · filed 2026-06-29 |
| 2025-12-31 | $27.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-17 | $59.36K derived: sum of 2 quarters · filed 2026-02-17 | $97.87K 10-Q · filed 2026-02-17 | $164.17K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $32.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | $70.61K 10-Q · filed 2025-11-14 | $136.92K derived: sum of 3 quarters · filed 2026-08-13 | $242.06K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $38.51K 10-Q · filed 2026-08-13 | $104.81K derived: sum of 2 quarters · filed 2026-08-13 | $209.95K derived: sum of 3 quarters · filed 2026-08-13 | $313.79K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $66.30K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $171.44K derived: sum of 2 quarters · filed 2026-06-29 | $275.28K derived: sum of 3 quarters · filed 2026-06-29 | $378.86K 10-K · filed 2026-06-29 |
| 2024-12-31 | $105.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-17 | $208.98K derived: sum of 2 quarters · filed 2026-02-17 | $312.55K 10-Q · filed 2026-02-17 | $363.35K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | $103.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | $207.41K 10-Q · filed 2025-11-14 | $258.21K derived: sum of 3 quarters · filed 2025-11-14 | $295.79K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $103.58K 10-Q · filed 2025-08-14 | $154.38K derived: sum of 2 quarters · filed 2025-08-14 | $191.95K derived: sum of 3 quarters · filed 2025-08-14 | $246.45K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $50.80K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-30 | $88.37K derived: sum of 2 quarters · filed 2025-06-30 | $142.87K derived: sum of 3 quarters · filed 2025-06-30 | $185.65K 10-K · filed 2025-06-30 |
| 2023-12-31 | $37.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $92.07K derived: sum of 2 quarters · filed 2025-02-13 | $134.85K 10-Q · filed 2025-02-13 | $285.75K derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $54.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-14 | $97.28K 10-Q · filed 2024-11-14 | $248.18K derived: sum of 3 quarters · filed 2024-11-14 | $325.55K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $42.78K 10-Q · filed 2024-08-14 | $193.68K derived: sum of 2 quarters · filed 2024-08-14 | $271.05K derived: sum of 3 quarters · filed 2024-08-14 | $320.92K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $150.91K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-01 | $228.28K derived: sum of 2 quarters · filed 2024-07-01 | $278.14K derived: sum of 3 quarters · filed 2024-07-01 | $381.68K 10-K · filed 2024-07-01 |
| 2022-12-31 | $77.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-14 | $127.23K derived: sum of 2 quarters · filed 2024-02-14 | $230.77K 10-Q · filed 2024-02-14 | |
| 2022-09-30 | $49.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-14 | $153.40K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $103.54K 10-Q · filed 2023-08-14 |